Fresh Recalls

FDAClass II · Drug · Recall D-0637-2026 · Recalled June 24, 2026

Med Pride recall — Dabur India Limited

Agency report date: June 24, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Med Pride
Company / brand
Dabur India
Lot / serial / date codes
Lot# 022, 023 ,024, Within Expiry.
Distribution
US Nationwide.
Agency product description and boundaries

Med Pride, Bacitracin Zinc Ointment, 1oz (28.3g) per tube, 72 tubes per case, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC X004WB4LKT.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: CGMP Deviations; deficiencies observed during FDA inspection

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Med Pride

3. Open the official notice or contact

Official recall ID
D-0637-2026
Brand
Dabur India
Classification
Class II
Units affected
1185 tubes
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Dadra And Nagar Haveli, India
Firm address
225 - 4 - 1 Saily Village, Survey No, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Lot# 022, 023 ,024, Within Expiry.
Distribution
US Nationwide.
Firm notified the public via
E-Mail
FDA event ID
99137
Recall initiated
June 2, 2026
FDA classified
June 26, 2026
FDA report date
June 24, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page